Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)

被引:150
|
作者
Powell, Chelsea E. [1 ,4 ]
Gao, Yang [5 ,6 ]
Tan, Li [1 ,4 ]
Donovan, Katherine A. [1 ,4 ]
Nowak, Radoslaw P. [1 ,4 ]
Loehr, Amanda [5 ,6 ]
Bahcall, Magda [2 ]
Fischer, Eric S. [1 ,4 ]
Janne, Pasi A. [2 ,3 ]
George, Rani E. [5 ,6 ]
Gray, Nathanael S. [1 ,4 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02215 USA
[3] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02215 USA
[4] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[5] Harvard Med Sch, Dept Pediat Hematol & Oncol, Dana Farber Canc Inst, Boston, MA 02215 USA
[6] Harvard Med Sch, Childrens Hosp Boston, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
CELL LUNG-CANCER; INHIBITOR; RESISTANCE; POTENT;
D O I
10.1021/acs.jmedchem.7b01655
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We present the development of the first small molecule degraders that can induce anaplastic lymphoma kinase (ALK) degradation, including in non-small-cell lung cancer (NSCLC), anaplastic large-cell lymphoma (ALCL), and neuroblastoma (NB) cell lines. These degraders were developed through conjugation of known pyrimidine-based ALK inhibitors, TAE684 or LDK378, and the cereblon ligand pomalidomide. We demonstrate that in some cell types degrader potency is compromised by expression of drug transporter ABCB1. In addition, proteomic profiling demonstrated that these compounds also promote the degradation of additional kinases including PTK2 (FAK), Aurora A, FER, and RPS6KA1 (RSK1).
引用
收藏
页码:4249 / 4255
页数:7
相关论文
共 50 条
  • [31] Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
    Subbiahy, V.
    Kuraviy, S.
    Ganguly, S.
    Welch, D. R.
    Vivian, C. J.
    Mushtaq, M. U.
    Hegde, A.
    Iyer, S.
    Behrang, A.
    Ali, S. M.
    Madison, R. W.
    Venstrom, J. M.
    Jensen, R. A.
    McGuirk, J. P.
    Amin, H. M.
    Balusu, R.
    ESMO OPEN, 2021, 6 (04)
  • [32] Anaplastic Lymphoma Kinase (ALK)-negative systemic anaplastic large cell lymphoma presenting as zosteriform skin nodules
    Ahuja, Rhea
    Patel, Varniraj
    Mallick, Saumayaranjan
    Damle, Nishikant
    Sharma, Atul
    Gupta, Vishal
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (03): : 358 - 362
  • [33] Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors
    Lovly, C. M.
    de Stanchina, E.
    Chen, H.
    Liang, C.
    Pao, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
    Roskoski, Robert, Jr.
    PHARMACOLOGICAL RESEARCH, 2013, 68 (01) : 68 - 94
  • [35] STATUS OF ANAPLASTIC LYMPHOMA KINASE (ALK) GENE IN INFLAMMATORY BREAST CARCINOMA
    Krishnamurthy, S.
    Woodward, W.
    Reuben, J. M.
    Tepperberg, J.
    Ogura, D.
    Niwa, S.
    Ueno, N. T.
    CANCER RESEARCH, 2012, 72
  • [36] Timely topic: Anaplastic lymphoma kinase (ALK) spreads its influence
    Cheuk, W
    Chan, JKC
    PATHOLOGY, 2001, 33 (01) : 7 - 12
  • [37] Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers
    Kinoshita, Kazutomo
    Oikawa, Nobuhiro
    Tsukuda, Takuo
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 281 - 293
  • [38] Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
    Krishnamurthy, Savitri
    Woodward, Wendy
    Yang, Wei
    Reuben, James M.
    Tepperberg, James
    Ogura, Dai
    Niwa, Shin-ichiro
    Huo, Lei
    Gong, Yun
    El-Zein, Randa
    Gonzalez-Angulo, Ana M.
    Mac Gregor, Mariana Chavez
    Alvarez, Ricardo
    Lucci, Anthony
    Valero, Vicente
    Ueno, Naoto T.
    SPRINGERPLUS, 2013, 2 : 1 - 7
  • [39] Nucleophosmin (NPM) anaplastic lymphoma kinase(ALK) fusion transcript in malignant lymphoma.
    Kaneita, Y
    Uchida, T
    Irie, T
    Yasukawa, K
    Hanai, M
    Kura, Y
    Yamazaki, T
    Sawada, U
    Horie, T
    BLOOD, 1996, 88 (10) : 3465 - 3465
  • [40] The anaplastic lymphoma kinase (ALK) gene is associated with schizophrenia in a Chinese population
    Luan, Zhilin
    Zhang, Dai
    PSYCHIATRY RESEARCH, 2017, 258 : 612 - 613